Cargando…
Supplementation of the diet with the functional fiber PolyGlycoplex(® )is well tolerated by healthy subjects in a clinical trial
BACKGROUND: The relationship of dietary fiber to overall health is of great importance, as beneficial effects have been demonstrated with the use of fiber from diverse sources, some traditional, other novel. PolyGlycopleX(® )(PGX(®)) is a unique proprietary product composed of three water-soluble po...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657159/ https://www.ncbi.nlm.nih.gov/pubmed/19196472 http://dx.doi.org/10.1186/1475-2891-8-9 |
_version_ | 1782165567494422528 |
---|---|
author | Carabin, Ioana G Lyon, Michael R Wood, Simon Pelletier, Xavier Donazzolo, Yves Burdock, George A |
author_facet | Carabin, Ioana G Lyon, Michael R Wood, Simon Pelletier, Xavier Donazzolo, Yves Burdock, George A |
author_sort | Carabin, Ioana G |
collection | PubMed |
description | BACKGROUND: The relationship of dietary fiber to overall health is of great importance, as beneficial effects have been demonstrated with the use of fiber from diverse sources, some traditional, other novel. PolyGlycopleX(® )(PGX(®)) is a unique proprietary product composed of three water-soluble polysaccharides, that when processed using novel technology give rise to a final product – a soluble, highly viscous functional fiber. METHODS: Because of its potential use in food and dietary supplements, a randomized, double-blind, placebo controlled clinical study was conducted to evaluate the tolerance to PGX ingestion for 21 days, to a maximum dose level of 10 g per day, in healthy male and female volunteers. The main objective of the study was to evaluate the overall gastrointestinal (GI) tolerance, while secondary objectives were to evaluate possible changes in hematological, biochemical, urinary and fecal parameters. RESULTS: Results show that PGX is well tolerated as part of a regular diet with only mild to moderate adverse effects, similar to those seen with a moderate intake of dietary fiber in general, and fruits and vegetables. Because PGX is a highly viscous, functional fiber, it also demonstrates several physiological responses including, but not limited to maintaining healthy total and LDL cholesterol and uric acid levels. |
format | Text |
id | pubmed-2657159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26571592009-03-18 Supplementation of the diet with the functional fiber PolyGlycoplex(® )is well tolerated by healthy subjects in a clinical trial Carabin, Ioana G Lyon, Michael R Wood, Simon Pelletier, Xavier Donazzolo, Yves Burdock, George A Nutr J Research BACKGROUND: The relationship of dietary fiber to overall health is of great importance, as beneficial effects have been demonstrated with the use of fiber from diverse sources, some traditional, other novel. PolyGlycopleX(® )(PGX(®)) is a unique proprietary product composed of three water-soluble polysaccharides, that when processed using novel technology give rise to a final product – a soluble, highly viscous functional fiber. METHODS: Because of its potential use in food and dietary supplements, a randomized, double-blind, placebo controlled clinical study was conducted to evaluate the tolerance to PGX ingestion for 21 days, to a maximum dose level of 10 g per day, in healthy male and female volunteers. The main objective of the study was to evaluate the overall gastrointestinal (GI) tolerance, while secondary objectives were to evaluate possible changes in hematological, biochemical, urinary and fecal parameters. RESULTS: Results show that PGX is well tolerated as part of a regular diet with only mild to moderate adverse effects, similar to those seen with a moderate intake of dietary fiber in general, and fruits and vegetables. Because PGX is a highly viscous, functional fiber, it also demonstrates several physiological responses including, but not limited to maintaining healthy total and LDL cholesterol and uric acid levels. BioMed Central 2009-02-05 /pmc/articles/PMC2657159/ /pubmed/19196472 http://dx.doi.org/10.1186/1475-2891-8-9 Text en Copyright © 2009 Carabin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Carabin, Ioana G Lyon, Michael R Wood, Simon Pelletier, Xavier Donazzolo, Yves Burdock, George A Supplementation of the diet with the functional fiber PolyGlycoplex(® )is well tolerated by healthy subjects in a clinical trial |
title | Supplementation of the diet with the functional fiber PolyGlycoplex(® )is well tolerated by healthy subjects in a clinical trial |
title_full | Supplementation of the diet with the functional fiber PolyGlycoplex(® )is well tolerated by healthy subjects in a clinical trial |
title_fullStr | Supplementation of the diet with the functional fiber PolyGlycoplex(® )is well tolerated by healthy subjects in a clinical trial |
title_full_unstemmed | Supplementation of the diet with the functional fiber PolyGlycoplex(® )is well tolerated by healthy subjects in a clinical trial |
title_short | Supplementation of the diet with the functional fiber PolyGlycoplex(® )is well tolerated by healthy subjects in a clinical trial |
title_sort | supplementation of the diet with the functional fiber polyglycoplex(® )is well tolerated by healthy subjects in a clinical trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657159/ https://www.ncbi.nlm.nih.gov/pubmed/19196472 http://dx.doi.org/10.1186/1475-2891-8-9 |
work_keys_str_mv | AT carabinioanag supplementationofthedietwiththefunctionalfiberpolyglycoplexiswelltoleratedbyhealthysubjectsinaclinicaltrial AT lyonmichaelr supplementationofthedietwiththefunctionalfiberpolyglycoplexiswelltoleratedbyhealthysubjectsinaclinicaltrial AT woodsimon supplementationofthedietwiththefunctionalfiberpolyglycoplexiswelltoleratedbyhealthysubjectsinaclinicaltrial AT pelletierxavier supplementationofthedietwiththefunctionalfiberpolyglycoplexiswelltoleratedbyhealthysubjectsinaclinicaltrial AT donazzoloyves supplementationofthedietwiththefunctionalfiberpolyglycoplexiswelltoleratedbyhealthysubjectsinaclinicaltrial AT burdockgeorgea supplementationofthedietwiththefunctionalfiberpolyglycoplexiswelltoleratedbyhealthysubjectsinaclinicaltrial |